A recent study suggests that individuals with elevated vitamin D levels during midlife may experience reduced tau protein levels in the brain years later. This research, published on April 1, 2026, in Neurology Open Access, the official journal of the American Academy of Neurology, highlights the potential link between vitamin D and dementia. Tau protein has been closely associated with the development of dementia.
Researchers emphasize that while these findings indicate a correlation, they do not establish a direct causal relationship between vitamin D levels and a reduction in tau protein or dementia risk.
“These results suggest that higher vitamin D levels in midlife may provide a protective effect against the accumulation of tau deposits in the brain. Conversely, low vitamin D levels could represent a modifiable risk factor for dementia,” stated study author Martin David Mulligan, MB BCh BAO, from the University of Galway in Ireland. “However, additional studies are necessary to validate these findings.”
Long-Term Study Monitors Vitamin D and Brain Biomarkers
The study tracked 793 adults, averaging 39 years of age and free from dementia at the outset. Researchers assessed the blood vitamin D levels of each participant at the beginning of the study.
Approximately 16 years later, participants underwent brain scans to examine their levels of tau and amyloid beta proteins, which are recognized as biomarkers for Alzheimer’s disease. A vitamin D level above 30 nanograms per milliliter (ng/mL) was classified as high, while levels below this were deemed low.
In total, 34% of participants had low vitamin D levels, with only 5% indicating they were taking vitamin D supplements.
Association Between Higher Vitamin D and Reduced Tau Protein
After adjusting for variables such as age, sex, and depressive symptoms, the researchers found that higher vitamin D levels were associated with lower tau protein levels many years later.
However, there was no observed relationship between vitamin D levels and the amount of amyloid beta protein in the brain.
“These findings are encouraging as they imply a potential connection between higher vitamin D levels in early middle age and a reduced tau burden approximately 16 years later,” Mulligan noted. “Midlife offers a critical period for risk factor modification that can yield significant benefits.”
Study Limitations and the Need for Further Investigation
One limitation of this study is that vitamin D levels were assessed on only one occasion, rather than monitored over time.
Key Takeaways:
- Higher vitamin D levels in midlife were associated with lower tau protein levels later, a significant marker for Alzheimer’s disease
- The study indicates a correlation but does not demonstrate that vitamin D directly mitigates dementia risk
- No connection was found between vitamin D levels and amyloid beta, another key Alzheimer’s biomarker
- Further research is needed to confirm these results and gain a deeper understanding of vitamin D’s role in brain health
The study received support from the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Irish Research Council, and the Health Research Board of Ireland.
In summary, this research underscores the potential influence of vitamin D levels during midlife on brain health and tau protein accumulation. Continued exploration in this area could pave the way for new preventive measures against dementia.
